Effects of a short prednisone regime at clinical onset of type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 20, Issue 1, 1993, Pages 39-46

  Goday, Albert ^a   Pujol Borrell, Ricardo ^b   Fernandez, Josefa ^a   Casamitjana, Roser ^a   Rios, Martin ^c   Vilardell, Enric ^a   Gomis, Ramon ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Autoimmunity; Immunosuppression; Islet cell antibodies; Prednisone; Type 1 diabetes

Indexed keywords

C PEPTIDE; GLUCAGON; INSULIN; INSULIN ANTIBODY; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; AUTOANTIBODIES; C-PEPTIDE; COMPARATIVE STUDY; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; HISTOCOMPATIBILITY TESTING; HUMAN; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; MALE; MULTIVARIATE ANALYSIS; PREDNISONE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0027217375     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(93)90020-6     Document Type: Article

References (33)

1. Mechanisms of autoimmunity: Relevance to the pathogenesis of type 1 (insulin-dependent) diabetes mellitus
2. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset
3. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus
4. Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics
5. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset
6. Factors associated with early remission of type 1 diabetes in children treated with cyclosporine
7. Cyclosporin A in insulin-dependent diabetes mellitus of recent onset: A pilot study in children
8. Partial preservation of pancreatic β-cell function in children with diabetes
9. Prednisone treatment in newly diagnosed type 1 diabetic children: 1 yr follow-up
10. Increase in remission rate in newly diagnosed type 1 diabetic subjects treated with azathioprine
11. Double blind controlled trial of azathioprine in children with newly diagnosed type 1 diabetes
12. Immunosuppression with azathioprine and prednisone in recent onset insulin dependent diabetes mellitus
13. Idiopathic thrombocytopenic purpura. To treat or not to treat
14. Autoimmune hemolitic anemia
15. A comparison of childhood and adult type 1 diabetes mellitus
16. Factors influencing the magnitude, duration and fall of B-cell function in Type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis
17. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients
18. Correlation between residual beta cell function and islet cell antibodies (ICA) in newly diagnosed type 1 diabetes: A follow up study
19. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin dependent) diabetes mellitus in children
20. Presence of insulin autoantibodies at clinical diagnosis of Diabetes Mellitus type 1 predicts loss of beta cell function
21. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
22. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
23. Immunology and Diabetes Workshop: Report of the Second International Workshop on the Standarisation of Cytoplasmic Islet Cell Antibodies
24. Prevalence of islet cell antibodies, insulin antibodies and hyperglycemia in 2291 schoolchildren
25. Wilkins, T.J., Schoenfeld, S.L., Diaz, J.L., Kruse, V., Bonifacio, E. and Palmer, J.P. Systematic variation and differences in insulin-autoantibody measurements. Diabetes 38, 172–181.
26. Radioimmunoassay of human proinsulin C peptide using synthetic human connecting peptide
27. Evaluation and comparison of 10 glucose methods and the reference method recommended in the product class standard
28. Hemoglobina glicosilada como indice de control de la diabetes mellitus
29. Serotyping for homotransplantation XVIII. Refinement of microdroplet lymphocyte cytotoxicity test
30. C-Peptide and proinsulin
31. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients
32. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus